期刊文献+

艾司西酞普兰与舍曲林治疗老年抑郁症对照研究 被引量:15

Efficacy and Safety of Escitalopram and Sertraline in the Treatment of Senile Patients with Depression
原文传递
导出
摘要 目的评价艾司西酞普兰治疗老年抑郁症疗效及安全性。方法 64例老年抑郁症患者随机分为艾司西酞普兰组与舍曲林组,疗程6周。采用汉密尔顿抑郁量表(HAMD)评定临床疗效,不良反应量表(TESS)评定不良反应。结果艾司西酞普兰组显效率为78.1%,舍曲林组75%,两组比较差异无显著性(χ2=0.22,P>0.05);艾司西酞普兰组治疗第2周末与舍曲林组HAMD评分比较有显著性差异(t=3.66,P<0.05);艾司西酞普兰组不良反应发生率40.6%,舍曲林组43.8%,两组比较差异无显著性(χ2=0.06,P>0.05)。结论艾司西酞普兰与舍曲林治疗老年抑郁症疗效相当,艾司西酞普兰起效较舍曲林快。 Objective To explore the efficacy and safety of escitalopram and sertraline in the treatment of senile patients with depression.Methods A total of 64 senile patients with depression were randomly assigned into escitalopram group and sertraline group for 6 weeks.Clinical effectiveness were evaluated by HAMD,and adverse reactions were assessed with TESS.Results The response rate was 78.1% in escitalopram group and 75% in sertraline group,and there was no significant difference between two groups(χ2=0.22,P0.05).At the end of 2 week treatment,there was significant difference in the scores of HAMD between two groups(t=3.66,P0.05).The adverse reactions were 40.6% in escitalopram group and 43.8% in sertraline group,and there was no significant difference between two group(χ2=0.06,P0.05).Conclusions The efficacy of escitalopram in treating senile depression is similar to those of sertraline.Escitalopram takes effect more quickly than sertraline.
作者 常双海
出处 《中国健康心理学杂志》 2012年第9期1296-1297,共2页 China Journal of Health Psychology
关键词 抑郁症 舍曲林 艾司西酞普兰 老年人 Depression Sertraline Escitralopram The aged
  • 相关文献

参考文献4

  • 1Colonna L, Andersen H F, Reins E H. A randomized, double-- blind, 2 4 -- week study of escitalopram (10mg/d) versus citalopram ( 2 0mg/ d)in primary with major depressive disorder[J]. Curr Med Resopin, 2005,21 (I0) : 1659-1668.
  • 2Owens M J. Knight D L,Nemeroff C B. Second generation SSRI: Human monoamine transporter blinding profile of escitalopram and R -- fluoretine [J]. Biol Psychiatry, 2001,50 : 345-350.
  • 3司天梅,舒良.关于新抗抑郁药艾司西酞普兰[J].临床精神医学杂志,2007,17(1):68-69. 被引量:124
  • 4王雪艳,孙波,张永东,刘瑞华,王立钢,王克.艾司西酞普兰与马普替林治疗抑郁症对照研究[J].临床精神医学杂志,2007,17(5):324-324. 被引量:11

二级参考文献16

  • 1王玉伟,杨丽芹,孙静,邵长春.西酞普兰与氟西汀治疗抑郁症对照研究[J].临床精神医学杂志,2004,14(4):225-226. 被引量:69
  • 2Owens MJ,Knight DL,Nemeroff CB.Second generation SSRIs:human monoamine transporter binding profile of escitalopram and R-fluoxetine[J].Biol Psychiatry,2001,50:345-350.
  • 3Chen FH,Larsen MB,Sanchezc,et al.The S-enantiomer of R,S-citalopram,increases inhibitor binding to the human serotonin transporter by an allosteric mechanism.Comparison with other serotonin transporter inhibitors[J].Eur Neuropsychopharmacology,2005,15:193-198.
  • 4Mork A,Kreilgaard M,Sanchez C.The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats[J].Neuropharmacology,2003,45:167-173.
  • 5Sanchez C.R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalization model[J].Eur J Pharmacol,2003,464:155-158.
  • 6Sanchez C,Gruca P,Papp M.R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model of depression[J].Behav Pharmacol,2003,14:465-470.
  • 7Plenge P,Mellerup ET,Laursen H.Affinity modulation of[^3H]imipramine,[^3H]paroxetine and[^3H]citalopram binding to the 5-HT transporter from brain and platelets[J].Eur J Pharmacol,1991,206:243-250.
  • 8Fava M,Davidson KG.Definition and epidemiology of treatment resistant depression[J].Psychiatr Clin North Am,1996,19:179-200.
  • 9Thase ME.The Concept of Remission:validity and limitations[J].JClin Psychiatry,2006,67:478-481.
  • 10Thase ME.Evaluating antidepressant therapies:Remission as the optimal outcome[J].J Clin Psychiatry,2003,64(Suppl 13):18-25.

共引文献124

同被引文献133

引证文献15

二级引证文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部